Home/Filings/4/0001791222-25-000003
4//SEC Filing

Coleman Charles S. 4

Accession 0001791222-25-000003

CIK 0001395942other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 1:49 PM ET

Size

14.7 KB

Accession

0001791222-25-000003

Insider Transaction Report

Form 4
Period: 2025-12-02
Coleman Charles S.
EVP, CLO & Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-02$18.23/sh+29,354$535,12382,828.483 total
  • Sale

    Common Stock

    2025-12-02$26.00/sh29,354$763,11653,474.483 total
  • Exercise/Conversion

    Common Stock

    2025-12-02$18.23/sh+58,708$1,070,247112,182.483 total
  • Sale

    Common Stock

    2025-12-02$26.00/sh58,708$1,526,17353,474.483 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-12-02$18.23/sh29,354$535,1230 total
    Exercise: $18.23Exp: 2031-06-04Common Stock (29,354 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-12-02$18.23/sh58,708$1,070,24758,709 total
    Exercise: $18.23Exp: 2031-06-04Common Stock (58,708 underlying)
Footnotes (4)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.930 to $26.065 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.920 to $26.065 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]These options were granted on June 4, 2021 and vested and became exercisable in equal installments on each of the first four anniversaries of the grant date, and were subject to continued employment through such vesting date.
  • [F4]These options were granted on June 4, 2021 and will become eligible to vest and become exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $23.23, $28.23, $33.23, and $38.23, for twenty consecutive trading days, subject to continued employment through such vesting date.

Issuer

OPENLANE, Inc.

CIK 0001395942

Entity typeother

Related Parties

1
  • filerCIK 0001791222

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 1:49 PM ET
Size
14.7 KB